GPRC5B and obesity disorder: In global GPRC5B-KO mice, circulating insulin levels were reduced especially in diet-induced obesity (13, 17), but since KOs also showed a lean phenotype with reduced insulin resistance and lower obesity-associated inflammation (13), these changes might have been secondary.